"Hepatitis, Autoimmune" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.
| Descriptor ID |
D019693
|
| MeSH Number(s) |
C06.552.380.350.050 C20.111.567
|
| Concept/Terms |
Hepatitis, Autoimmune- Hepatitis, Autoimmune
- Autoimmune Hepatitides
- Hepatitides, Autoimmune
- Autoimmune Chronic Hepatitis
- Autoimmune Chronic Hepatitides
- Chronic Hepatitides, Autoimmune
- Chronic Hepatitis, Autoimmune
- Hepatitides, Autoimmune Chronic
- Hepatitis, Autoimmune Chronic
- Autoimmune Hepatitis
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis, Autoimmune".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis, Autoimmune".
This graph shows the total number of publications written about "Hepatitis, Autoimmune" by people in this website by year, and whether "Hepatitis, Autoimmune" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis, Autoimmune" by people in Profiles.
-
AhR Activation Leads to Attenuation of Murine Autoimmune Hepatitis: Single-Cell RNA-Seq Analysis Reveals Unique Immune Cell Phenotypes and Gene Expression Changes in the Liver. Front Immunol. 2022; 13:899609.
-
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2017 Aug; 15(8):1207-1217.e4.
-
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease. Int Rev Immunol. 2015; 34(5):403-14.
-
Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PLoS One. 2011 Apr 01; 6(4):e18281.
-
Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis. Am J Hematol. 2010 Aug; 85(8):627-9.
-
Risk of non-melanoma skin cancer in autoimmune hepatitis. Dig Dis Sci. 2010 Nov; 55(11):3218-23.
-
Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis. Vitam Horm. 2009; 81:487-504.
-
Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis. J Clin Gastroenterol. 2008 Aug; 42(7):862-3.
-
Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol Pharmacol. 2008 Jul; 74(1):20-33.
-
Prevalence of IgG autoantibody against F-actin in patients suspected of having autoimmune or acute viral hepatitis. J Clin Lab Anal. 2007; 21(4):249-53.